Welcome to our dedicated page for McEwen SEC filings (Ticker: MUX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
McEwen Inc. filings document operating results, mineral-project disclosures, governance matters and capital-structure information for a metals mining company with common stock registered on the New York Stock Exchange under MUX. Form 8-K reports furnish quarterly and annual financial and operating results, Regulation FD updates, drill results and mineral resource disclosures for projects such as Gold Bar and Tartan.
Proxy filings cover annual meeting matters including director elections, auditor ratification and share-issuance proposals under exchange listing rules. The filing record also includes notices related to annual-report timing, exhibits to material-event reports, security registration details and disclosures involving shareholder votes, material agreements and corporate governance.
Richard W. Brissenden, a director of McEwen Inc. (MUX), was granted a stock option that gives him the right to purchase up to 20,000 common shares at an exercise price of $10.43 per share. The option was recorded with an effective transaction date of 08/11/2025 and shows an expiration date of 08/11/2030. The grant vests in three equal annual installments beginning 08/11/2026, and the shares underlying the option are reported as directly owned by the reporting person following the transaction.
This Form 4 discloses the specific terms of the derivative award (exercise price, number of shares, vesting schedule and expiration) but does not provide information on total insider holdings relative to outstanding shares or any cash payments made in connection with the grant.
McEwen Inc. General Counsel Carmen L. Diges reported acquisitions of equity awards tied to the issuer's common stock. On 08/11/2025 she acquired 40,000 stock options with an exercise price of $10.43 and 3,900 restricted stock units. The option award is subject to a vesting schedule that begins on August 11, 2026 and vests in three equal annual installments. Each restricted stock unit represents a contingent right to one share or cash and vests in three equal installments on December 29, 2025, June 29, 2026 and December 29, 2026.
The reporting form shows these holdings as direct beneficial ownership. The filings identify Ms. Diges as an officer serving as General Counsel and Corporate Secretary and list the number of securities beneficially owned following the transactions as 40,000 options and 3,900 RSUs.
McEwen Inc. director Michael Nelson Melanson was granted 10,000 stock options on 08/11/2025 with an exercise (conversion) price of $10.43. The filing reports these options as directly beneficially owned by Mr. Melanson following the grant and shows no cash purchase associated with the grant.
The options vest in three equal annual installments beginning August 11, 2026 and expire on August 11, 2030. The filing is a single-person Form 4 reporting this equity award to a company director; it contains no other transactions, cash exercises, or changes in outstanding common stock reported.
McEwen Inc. director Dalia Nadine Asterbadi was granted a stock option for 10,000 shares of common stock with a $10.43 exercise price on 08/11/2025. The option vests in three equal annual installments beginning 08/11/2026 and is exercisable through 08/11/2030, and the reporting person is shown as the direct beneficial owner of 10,000 options following the transaction.
This grant ties a board member’s compensation to the company’s share performance and creates potential future dilution if the options are exercised, while the staged vesting supports retention over the next three years.
William M. Shaver, who serves as Chief Operating Officer and a director of McEwen Inc. (MUX), was granted equity awards on 08/11/2025 consisting of a stock option and restricted stock units. The stock option gives the right to buy 80,000 shares at an exercise price of $10.43, vests in three equal annual installments beginning August 11, 2026, is exercisable through August 11, 2030, and is held directly. The restricted stock units total 6,300, represent the contingent right to one share (or cash at the issuer's discretion), and vest in three installments on December 29, 2025, June 29, 2026 and December 29, 2026.
The reported transactions are grants (acquisitions) rather than dispositions. Following the awards the filing shows beneficial ownership of 80,000 option interests and 6,300 RSUs held directly by Mr. Shaver. The disclosure is a routine insider compensation event providing equity linkage between management and common stock performance.
John Casimir Florek, a director of McEwen Inc. (MUX), was granted 10,000 stock options with an exercise price of $10.43. The transaction is recorded with an effective date of 08/11/2025. The options are classified as a stock option (right to buy) and are held directly by Mr. Florek following the reported transaction.
The award vests in three equal annual installments beginning 08/11/2026 and expires on 08/11/2030. In practical terms, the grant ties part of a director's potential compensation to the company's share price, while the staggered vesting delays any immediate exercise; full realization would require exercise at or above the $10.43 strike and would introduce up to 10,000 additional shares on exercise.
McEwen Inc. director Nicolas Darveau-Garneau was granted 20,000 stock options on 08/11/2025 with an exercise price of $10.43. The options give the right to buy common stock and are reported as held directly.
The grant vests in three equal annual installments beginning 08/11/2026 and includes an apparent expiration date of 08/11/2030. The filing lists the acquisition of 20,000 derivative securities (stock options) under the Form 4 disclosure.
McEwen Inc. (MUX) reported equity awards to its Chief Financial Officer, Perry Ing, reflecting a compensation grant recorded on 08/11/2025. The grant consists of 50,000 stock options with an exercise price of $10.43 and 5,600 restricted stock units (RSUs). After the reported transactions the reporting person beneficially owns 50,000 option rights and 5,600 RSU rights shown on the form as direct holdings.
The option award vests in three equal annual installments beginning August 11, 2026 and the option has an indicated expiration or last date of 08/11/2030. Each RSU represents a contingent right to one share (or cash at the issuer's discretion) and will vest in three approximately equal installments on December 29, 2025, June 29, 2026 and December 29, 2026. The Form 4 lists these as acquisitions (Transaction Code A) and identifies the awards as direct beneficial ownership.
Alfred Aguilar Colas, identified as a director of McEwen Inc. (MUX), acquired 10,000 stock options on 08/11/2025 with an exercise price of $10.43. The options cover 10,000 shares of common stock, are reported as directly beneficially owned following the transaction, and have an expiration date of 08/11/2030.
The filing states the options vest in three equal annual installments beginning 08/11/2026. The transaction is reported as an acquisition (code "A") and the form indicates it was filed by one reporting person.
Stephen Douglas Kaszas, a director of McEwen Inc. (MUX), was granted a stock option on 08/11/2025 to buy 10,000 shares of common stock at an exercise price of $10.43. The Form 4 reports the option as an acquisition and shows 10,000 derivative securities beneficially owned following the transaction, held directly. The option vests in three equal annual installments beginning August 11, 2026 and the option expires on August 11, 2030. The filing was made by one reporting person and identifies Kaszas relationship to the issuer as a director.